July 23 (Reuters) – German pharmaceutical company Sartorius reported half-year earnings slightly above market expectations on Thursday, citing stable recurring business and the effect of U.S. tariff refunds.
The company reported an underlying earnings margin before interest, taxes, depreciation and amortization of 30.3%, just above a Vara consensus of 30%.
It also confirmed its guidance for the full year 2026.
($1 = 0.8748 euros)
(Reporting by Cian Muenster and Basille Day, editing by Milla Nissi-Prussak)
